VADUZ, Liechtenstein, Aug. 23, 2022 /PRNewswire/ Executing on RefluxStop Commercialisation Strategy Significant events in the second quarter of 2022 Implantica has completed
Clarius Applauded by Frost & Sullivan with 2022 North American Portable Ultrasound Technology Innovation Leadership Award for Enabling High-Quality and More Affordable Ultrasound Imaging With its HD3 App-Based Scanners finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Clarius Mobile Health announced today that it has received Frost & Sullivan s 2022 Best Practices Technology Innovation Leadership Award in the.
The RefluxStop device prevents the regurgitation of stomach fluid into the esophagus and addresses the limitations of proton pump inhibitors (PPIs) and existing surgical methods and devices for treating acid reflux disease. SAN ANTONIO, June 16, 2022 /PRNewswire/ - Frost & Sullivan recently assessed the European gastroesophageal reflux disease (GERD) treatment industry and, based on its findings, recognizes Implantica with the 2022 European Technology Innovation Leadership Award for its GERD therapy device. The company developed the RefluxStop device, a CE-marked, first-of-its-kind single-use sterile medical implant, for acid reflux treatment. The device prevents the regurgitation of stomach fluid into the esophagus and addresses the limitations of commonly used drug treatment, Proton Pump Inhibitors (PPIs) and current surgical methods for treating acid reflux disease. The RefluxStop device is placed outside of the top part of the stomach (fundus wall) during laparoscopic surgery,